| Business Summary | | Regeneration
Technologies
is
engaged
in
the
use
of
natural
tissue
and
technologies
to
repair
and
promote
the
natural
healing
of
human
bone
and
other
human
tissues.
The
Company
processes
human
musculoskeletal
and
other
tissue,
including
bone,
cartilage,
tendon,
ligament,
pericardial
and
cardiovascular
tissue
in
producing
its
allografts.
Surgeons
then
use
these
tissues
to
repair
and
promote
the
healing
of
bone
and
other
tissue
defects,
including
spinal
vertebrae
repair,
musculoskeletal
reconstruction,
fracture
repair,
repairs
to
the
jaw
and
related
tissues,
urinary
incontinence
and
heart
valve
disorders. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Regeneration
Technologies
is
a
provider
of
healing
and
natural
tissue
products
to
repair
and
promote
the
natural
healing
of
human
bone
and
other
human
tissues,
and
is
also
a
processor
and
distributor
of
allografts.
For
the
six
months
ended
6/30/01,
net
revenues
rose
35%
to
$34.1
million.
Net
income
fell
13%
to
$1.1
million.
Results
reflect
higher
revenues
from
the
distribution
of
spinal
allografts,
offset
by
increased
marketing
and
administrative
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| James Grooms, 40 Chairman,
Pres, CEO | $225K | Richard Allen CFO,
Sec., Treasurer | 150K | Frederick Preiss VP-Operations | 157K | James Abraham VP
of Sales and Marketing | 207K | Thomas Brewer VP
of Marketing | 156K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|